Session » Vasculitis - Poster II: ANCA-Associated Vasculitis
-
Abstract Number: 1923
Activated Partial Thromboplastin Time Reflects Disease Activity in Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
-
Abstract Number: 1924
Clinical Features and Outcome in Patients with Elderly Onset ANCA Associated Vasculitis
-
Abstract Number: 1925
Interest of Procalcitonin for the Follow-up of ANCA-Associated Vasculitis: Data from a Cohort of 99 Patients
-
Abstract Number: 1926
Indications for Testing and Diagnostic Outcome in Patients with Positive ANCA at a Canadian Tertiary Care Centre
-
Abstract Number: 1927
Relapses in Patients with ANCA-Associated Vasculitis: A Retrospective Study on Severity and Organ Involvement Compared to Initial Onset
-
Abstract Number: 1928
Treatment of ANCA Associated Vasculitis in the Very Elderly
-
Abstract Number: 1929
Comparison of Two Different ANCA Iif Methods with EIA and Disease Phenotype
-
Abstract Number: 1930
Factors Associated with Glucocorticoid Exposure in ANCA-Associated Vasculitis
-
Abstract Number: 1931
MRI Findings in Granulomatosis with Polyangiitis: Pachymeningitis and Implications in Quality of Life
-
Abstract Number: 1932
Precapillary Pulmonary Hypertension in Granulomatosis with Polyangiitis: A Case Series with Long-Term Follow-up
-
Abstract Number: 1933
M2 Macrophage Is the Predominant Phenotype in Airways Inflammatory Lesions in Patients with Granulomatosis with Polyangiitis
-
Abstract Number: 1934
Cutaneous Manifestations of ANCA-Associated Vasculitis
-
Abstract Number: 1935
Hypertrophic Pachymeningitis in a Population with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Study in a Single Japanese Institution
-
Abstract Number: 1936
Clinical Characteristics of Inflammatory Eye Disease in Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Cohort Study
-
Abstract Number: 1937
Analysis of Innate and Adaptive Immune Responses in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss)
-
Abstract Number: 1938
Bronchiectasis Are Highly Prevalent in Anti-MPO ANCA-Associated Vasculitis and Associate with a Distinct Disease Phenotype
-
Abstract Number: 1939
Immunologic, Clinical and Demographic Correlates in 51 Cocaine Users with Serum Anti-Neutrophil Cytoplasmic Antibodies
-
Abstract Number: 1940
High Prevalence of Inflammatory Heart Disease in Eosinophillic Granulomatosis with Polyangiitis (Churg Strauss) Patients
-
Abstract Number: 1941
Retrospective Survey of Concomitant Autoimmune Diseases and Autoantibodies in a Cohort of Patients with ANCA-Associated Vasculitis (AAV)
-
Abstract Number: 1942
Presentation and Clinical Features of ANCA-Associated Vasculitis in US African Americans: Experience from a Single Center
-
Abstract Number: 1943
Factors Predictive of ANCA-Associated Vasculitis Relapse
-
Abstract Number: 1944
Disease Activity, Glucocorticoid Exposure, and Rituximab Determine Body Composition Changes during Induction Treatment of ANCA-Associated Vasculitis
-
Abstract Number: 1945
Development and Validation of Case-Finding Algorithms for the Identification of Patients with ANCA-Associated Vasculitis and Large-Vessel Vasculitis in Healthcare Administrative Databases
-
Abstract Number: 1946
Antineutrophil Cytoplasmic Antibody (ANCA) Type and Body Mass Index in ANCA-Associated Vasculitis (AAV)
-
Abstract Number: 1947
Ocular Manifestations of ANCA-Associated Vasculitis
-
Abstract Number: 1948
Evaluation of Body Composition Parameters in Granulomatosis with Polyangiitis: Association of Fat Mass Parameters with Disease Activity and Inflammatory Markers
-
Abstract Number: 1949
Presentation, Prognosis and Clinical-Pathological Correlations of Cutaneous Manifestations in ANCA-Associated Vasculitides
-
Abstract Number: 1950
ANCA-Associated Vasculitides and IgG4-Related Disease: An Overlapping Syndrome? a European Observational Study of 18 Patients
-
Abstract Number: 1951
Phenotypic and Functional Perturbations of Peripheral B and T Lymphocytes in Granulomatosis with Polyangiitis and Microscopic Polyangiitis
-
Abstract Number: 1952
Kv1.3 Channel Blockade Modulates the Effector Function of B Cells in Granulomatosis with Polyangiitis